Tags : Studies

Biosimilars Clinical Trials

Samsung Bioepis Reports Results of Renflexis (biosimilar, infliximab) from Two

Shots: The company reported results from two real-world studies of Renflexis (infliximab-abda) in patients with IBD registered in the US Veteran Affairs Healthcare System database. Data were presented at ACG 2020 One study assesses the safety of switching from reference infliximab or infliximab-dyyb to Renflexis in patients with IBD identified from the VAHS database and […]Read More